The pandemic has demonstrated the need for more diversity in the pharmaceutical supply chain, not less.

This plan delivers the right amount of aid to the right people, and minimizes the eventual drain on taxpayer dollars.

National emergencies can pose a threat to our federalist system of government. So far, President Trump has tried respect that federal-state balance of power.  

There are reasons to hope this crisis may pass sooner and with less economic and human damage than we are being led to believe.

This proposal would get substantial help directly to the people and businesses who need it, while minimizing the drain on the federal budget—unlike most of what’s being considered in Washington.